Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-21

FDA Approved: PREGABALIN — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for pregabalin from Ascend Laboratories, LLC (ANDA207799), indicating approval of a supplemental filing for this generic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

SUPPL AP for PREGABALIN (PREGABALIN)